Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLASDEGIB vs GLICLAZIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GLASDEGIB vs GLICLAZIDE: Safety Overview

Metric GLASDEGIB GLICLAZIDE
Total FAERS Reports 521 5,784
Deaths Reported 196 483
Death Rate 37.6% 8.4%
Hospitalizations 275 3,195
Average Patient Age 67.4 yrs 65.0 yrs
% Female Patients 38.6% 55.2%
FDA Approval Date Nov 21, 2018 N/A
Manufacturer Pfizer Laboratories Div Pfizer Inc N/A
Route ORAL N/A
Marketing Status Prescription N/A